Read about Sex Differences, Back to School Resources and more

["FDA Office of Women's Health" <fda@xxxxxxxxxxxxxxxxxxxxxxx>]

Title: Read about Sex Differences, Back to School Resources and more

August 2016
www.fda.gov/womens

Message from the Director

As we close out yet another busy summer, OWH is working to advance our many scientific and outreach projects. I encourage you to read this update to learn more about resources for back to school planning, clinical trials outreach and breastfeeding mothers. In addition, you will find opportunities to make your voice heard at FDA and other information on FDA regulated products. Follow us on Twitter to stay up to date on topics like Zika, clinical trials and other women’s health content that matter to you. 

Marsha Henderson, Assistant Commissioner for Women’s Health

FDA Women’s Health Highlights

New Blog: Busting 5 Common Myths about FDA and Women’s Health

FDA looks for sex differences when reviewing products and works to address sex differences and women’s health through our research, guidance for industry, scientific meetings, trainings, and other activities. Check out the latest OWH blog that counters common myths about FDA’s women’s health efforts. Read the “Busting 5 Common Myths about FDA and Women’s Health” blog post

Back To School Resources

Make health a priority this school year.  Prepare young children, teens and college students for school with these resources from FDA.

College Women’s Health Webpage Vaccines for Children: A Guide for Parents and Caregivers Medication Tips for Parents Youth Tobacco Prevention Campaigns Food Safety and Nutrition Materials for Kids and Teens

Spread the Word about Women in Clinical Trials

OWH’s Diverse Women in Clinical Trials Awareness Campaign continues to educate women about the importance of participating in clinical trials. Use our new partner toolkit to raise awareness in your community. The toolkit includes sample social media messages and other resources in English and Spanish to help in your outreach. Download the Women in Clinical Trials Toolkit

Extras

Public Workshop on Diabetes

On April 29, 2016, FDA’s Center for Drug Evaluation and Research (CDER), is sponsoring a public workshop entitled “Diabetes Outcome Measures Beyond Hemoglobin A1c (HbA1c).”

The purpose of this public workshop is to have a forum for dialogue on the extent to which the current regulatory paradigm for antidiabetic drug therapies addresses the needs of patients with diabetes and to identify additional outcomes, beyond HbA1c.

View the Meeting Announcement

---

Resources for Breastfeeding Mothers

FDA has tips to help breastfeeding mothers make informed decisions about FDA regulated products.  Use these tips to educate the women in your community.

• Learn the facts about breast pumps
• Visit FDA’s breast pumps website
• Read how FDA helps nursing mothers through improved prescription drug labeling
• Get other tips for pregnant and new mothers

Submit Comments on FDA Regulatory Activities

Nonclinical Evaluation of Osteoporosis Drugs

This docket is open until August 15, 2016.

---

OWH Conference Exhibits

National Black Nurses Association (NBNA) – August 2-7, Memphis, TN

American Association of Diabetes Educators (AADE) – August 12-15, San Diego, CA

National Association of Community Health Centers – August 28-30, Chicago, IL

Please share this update with your network, members, constituents, and community

FDA Office of Women's Health
10903 New Hampshire Avenue
WO32 - Room 2333
Silver Spring, MD 20993*0002
301-796-9440

---

Subscriber Services:
Manage Preferences  |  Unsubscribe  |  Help with this service

Stay Connected:

---

This email was sent to list-fda@xxxxxxxxxxx using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 1-888-INFO-FDA (1-888-463-6332)